.

出版周期:Semimonthly 自引率:3.

First decision without peer review. Decision Pending 2018-04-30 17:53:41.

.

.

. . The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with,.

Sep 16, 2022 · Authors can post their results in clinical trial registries or submit them to government regulatory agencies without the manuscript being considered previously published or an overlapping publication.

. Authors are requested to update any pre-publication versions with a. .

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed. .

The author is being contacted about the Editor-in-Chief's decision.

Recently, there has been burgeoning interest in developing more effective and robust clinical decision support systems (CDSSs) for oncology.

LetPub Scientific Journal Selector (2018-2021), CLINICAL CANCER RESEARCH published in 1995, UNITED STATES. .

. 5%.

In this article.
In this article.
.

Outreach plan: Provide a plan that describes how outreach will be conducted to promote the Program's research objectives , engage the biomedical community on precision cancer prevention-interception, provide research experiences to students, postdocs and early-stage investigators in precision cancer prevention interception, and.

( PLX) Pegunigalsidase alfa (Resubmitted BLA) 05/09/2023.

In clinical oncology the identification of potential prognostic factors –patient-related characteristics -is essential to assess a valuable prognosis, often independent from the treatment. . .

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with,. In this article. Sep 18, 2020 · class=" fc-falcon">Rather, it refers to the final decision by the Editor-in-Chief (EIC). NCI and Medical Decision Making. 83%.

.

Sep 13, 2022 · Outreach plan: Provide a plan that describes how outreach will be conducted to promote the Program's research objectives , engage the biomedical community on precision cancer prevention-interception, provide research experiences to students, postdocs and early-stage investigators in precision cancer prevention interception, and disseminate. .

The clinical trial must also be approved, done by, or paid for by certain government agencies or other accepted group.

.

May 20, 2023 · Janardhan Keshav Karapurkar, Min-Seong Kim, Jencia Carminha Colaco, Bharathi Suresh, Neha Sarodaya, Dong-Ho Kim, Chang-Hwan Park, Seok-Ho Hong, Kye-Seong Kim and Suresh Ramakrishna.

X Producing and Utilizing Posters - Beyond the Conference.

.